Screening of prostate cancer in asymptomatic men over 50 years is subj
ect to discussion. A review of the medical and economical arguments in
favor and against screening is given. It is concluded that widespread
screening should not be undertaken but that correct information of th
e population is necessary with an adapted response to individual deman
ds.